The EU is standing firm against U.S. plans to slap 100% tariffs on generic medicines by 2028, citing a 2023 trade deal signed in Turnberry that guarantees zero tariffs for European generics. With U.S. officials pushing to bring drug manufacturing home, the EU warns of potential U.S. medicine shortages and legal challenges loom as the administration faces scrutiny over whether these new levies violate the transatlantic agreement. Both sides recognize the critical role of pharmaceutical collaboration—and the stakes are high for patients and innovation across the Atlantic.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
